Skip to main content
Top
Published in: Diagnostic Pathology 1/2020

Open Access 01-12-2020 | Carotid Stenosis | Research

Diagnostic value of miR-186-5p for carotid artery stenosis and its predictive significance for future cerebral ischemic event

Authors: Weibo Lv, Tao Zhang, Hongwei Zhao, Shuang He, Bingwei Li, Yang Gao, Wenying Pan

Published in: Diagnostic Pathology | Issue 1/2020

Login to get access

Abstract

Background

MicroRNAs (miRNAs) serve as novel promising biomarkers for the diagnosis and prognosis of many human diseases. This study investigated the diagnostic value of miR-186-5p for asymptomatic carotid artery stenosis (CAS), and its predictive value for future cerebral ischemic events (CIEs).

Methods

Sixty-seven cases with asymptomatic CAS and 60 healthy individuals were recruited. Serum levels of miR-186-5p were tested by using qRT-PCR. Receiving–operator characteristic (ROC) curve was drawn based on sensitivity and specificity analyses. All asymptomatic CAS cases were followed up for 5 years. Kaplan-Meier method was applied for the evaluation of the predictive value of miR-186-5p for the occurrence of CIE.

Results

The serum level of miR-186-5p was increased significantly in asymptomatic CAS patients. MiR-186-5p was the most significant factor associated with the high degree of carotid stenosis in asymptomatic CAS patients. In the ROC curve analysis, the AUC was 0.919, with the sensitivity of 89.6% and specificity of 81.7% at the cutoff value of 1.221. Kaplan-Meier method results revealed that high miR-186-5p level was associated with the occurrence of CIEs. High miR-186-5p level and high degree of carotid stenosis were independent factors for the occurrence of CIEs.

Conclusion

MiR-186-5p serves as a potential diagnostic biomarker for patients with asymptomatic CAS, and predicts the occurrence of future CIEs.
Literature
1.
go back to reference Aday AW, Beckman JA. Medical management of asymptomatic carotid artery stenosis. Prog Cardiovasc Dis. 2017;59(6):585–90.PubMedCrossRef Aday AW, Beckman JA. Medical management of asymptomatic carotid artery stenosis. Prog Cardiovasc Dis. 2017;59(6):585–90.PubMedCrossRef
2.
go back to reference Aichner FT, Topakian R, Alberts MJ, Bhatt DL, Haring HP, Hill MD, et al. High cardiovascular event rates in patients with asymptomatic carotid stenosis: the REACH registry. Eur J Neurol. 2009;16(8):902–8.PubMedCrossRef Aichner FT, Topakian R, Alberts MJ, Bhatt DL, Haring HP, Hill MD, et al. High cardiovascular event rates in patients with asymptomatic carotid stenosis: the REACH registry. Eur J Neurol. 2009;16(8):902–8.PubMedCrossRef
3.
go back to reference Gokaldas R, Singh M, Lal S, Benenstein RJ, Sahni R. Carotid stenosis: from diagnosis to management, where do we stand? Curr Atheroscler Rep. 2015;17(2):480.PubMedCrossRef Gokaldas R, Singh M, Lal S, Benenstein RJ, Sahni R. Carotid stenosis: from diagnosis to management, where do we stand? Curr Atheroscler Rep. 2015;17(2):480.PubMedCrossRef
4.
go back to reference Wang Y, Zhang Q, Guo B, Feng J, Zhao D. miR-1231 is downregulated in prostate cancer with prognostic and functional implications. Oncol Res Treat. 2020;43(3):78-86. Wang Y, Zhang Q, Guo B, Feng J, Zhao D. miR-1231 is downregulated in prostate cancer with prognostic and functional implications. Oncol Res Treat. 2020;43(3):78-86.
5.
go back to reference Ma D, Tao X, Gao F, Fan C, Wu D. miR-224 functions as an onco-miRNA in hepatocellular carcinoma cells by activating AKT signaling. Oncol Lett. 2012;4(3):483–8.PubMedPubMedCentralCrossRef Ma D, Tao X, Gao F, Fan C, Wu D. miR-224 functions as an onco-miRNA in hepatocellular carcinoma cells by activating AKT signaling. Oncol Lett. 2012;4(3):483–8.PubMedPubMedCentralCrossRef
6.
go back to reference Jiang W, Li T, Wang J, Jiao R, Shi X, Huang X, et al. miR-140-3p suppresses cell growth and induces apoptosis in colorectal cancer by targeting PD-L1. Onco Targets Ther. 2019;12:10275–85.PubMedPubMedCentralCrossRef Jiang W, Li T, Wang J, Jiao R, Shi X, Huang X, et al. miR-140-3p suppresses cell growth and induces apoptosis in colorectal cancer by targeting PD-L1. Onco Targets Ther. 2019;12:10275–85.PubMedPubMedCentralCrossRef
7.
go back to reference Sun C, Zeng X, Guo H, Wang T, Wei L, Zhang Y, et al. MicroRNA-125a-5p modulates radioresistance in LTEP-a-2 non-small cell lung cancer cells by targeting SIRT7. Cancer Biomark. 2020;27(1):39-49. Sun C, Zeng X, Guo H, Wang T, Wei L, Zhang Y, et al. MicroRNA-125a-5p modulates radioresistance in LTEP-a-2 non-small cell lung cancer cells by targeting SIRT7. Cancer Biomark. 2020;27(1):39-49.
8.
go back to reference Hu Y, Ye H, Shi LX. MicroRNA-205 ameliorates lipid accumulation in non-alcoholic fatty liver disease through targeting NEU1. Eur Rev Med Pharmacol Sci. 2019;23(22):10072–82.PubMed Hu Y, Ye H, Shi LX. MicroRNA-205 ameliorates lipid accumulation in non-alcoholic fatty liver disease through targeting NEU1. Eur Rev Med Pharmacol Sci. 2019;23(22):10072–82.PubMed
9.
go back to reference Dolz S, Gorriz D, Tembl JI, Sanchez D, Fortea G, Parkhutik V, et al. Circulating MicroRNAs as novel biomarkers of stenosis progression in asymptomatic carotid stenosis. Stroke. 2017;48(1):10–6.PubMedCrossRef Dolz S, Gorriz D, Tembl JI, Sanchez D, Fortea G, Parkhutik V, et al. Circulating MicroRNAs as novel biomarkers of stenosis progression in asymptomatic carotid stenosis. Stroke. 2017;48(1):10–6.PubMedCrossRef
10.
go back to reference Han Z, Hu H, Yin M, Li X, Li J, Liu L, et al. miR-145 is critical for modulation of vascular smooth muscle cell proliferation in human carotid artery stenosis. J Biol Regul Homeost Agents. 2018;32(3):506–16.PubMed Han Z, Hu H, Yin M, Li X, Li J, Liu L, et al. miR-145 is critical for modulation of vascular smooth muscle cell proliferation in human carotid artery stenosis. J Biol Regul Homeost Agents. 2018;32(3):506–16.PubMed
11.
go back to reference Chen F, Li X, Li Z, Qiang Z, Ma H. Altered expression of MiR-186-5p and its target genes after spinal cord ischemia-reperfusion injury in rats. Neurosci Lett. 2020;718:134669. Chen F, Li X, Li Z, Qiang Z, Ma H. Altered expression of MiR-186-5p and its target genes after spinal cord ischemia-reperfusion injury in rats. Neurosci Lett. 2020;718:134669.
12.
go back to reference Liu X, Zhou X, Chen Y, Huang Y, He J, Luo H. miR-186-5p targeting SIX1 inhibits cisplatin resistance in non-small-cell lung cancer cells (NSCLCs). Neoplasma. 2020;67(1):147-157. Liu X, Zhou X, Chen Y, Huang Y, He J, Luo H. miR-186-5p targeting SIX1 inhibits cisplatin resistance in non-small-cell lung cancer cells (NSCLCs). Neoplasma. 2020;67(1):147-157.
13.
go back to reference Wang KJ, Zhao X, Liu YZ, Zeng QT, Mao XB, Li SN, et al. Circulating MiR-19b-3p, MiR-134-5p and MiR-186-5p are promising novel biomarkers for early diagnosis of acute myocardial infarction. Cell Physiol Biochem. 2016;38(3):1015–29.PubMedCrossRef Wang KJ, Zhao X, Liu YZ, Zeng QT, Mao XB, Li SN, et al. Circulating MiR-19b-3p, MiR-134-5p and MiR-186-5p are promising novel biomarkers for early diagnosis of acute myocardial infarction. Cell Physiol Biochem. 2016;38(3):1015–29.PubMedCrossRef
14.
go back to reference Yao Y, Zhang X, Chen HP, Li L, Xie W, Lan G, et al. MicroRNA-186 promotes macrophage lipid accumulation and secretion of pro-inflammatory cytokines by targeting cystathionine gamma-lyase in THP-1 macrophages. Atherosclerosis. 2016;250:122–32.PubMedCrossRef Yao Y, Zhang X, Chen HP, Li L, Xie W, Lan G, et al. MicroRNA-186 promotes macrophage lipid accumulation and secretion of pro-inflammatory cytokines by targeting cystathionine gamma-lyase in THP-1 macrophages. Atherosclerosis. 2016;250:122–32.PubMedCrossRef
15.
go back to reference Paciaroni M, Eliasziw M, Kappelle LJ, Finan JW, Ferguson GG, Barnett HJ. Medical complications associated with carotid endarterectomy. North American Symptomatic Carotid Endarterectomy Trial (NASCET). Stroke. 1999;30(9):1759–63.PubMedCrossRef Paciaroni M, Eliasziw M, Kappelle LJ, Finan JW, Ferguson GG, Barnett HJ. Medical complications associated with carotid endarterectomy. North American Symptomatic Carotid Endarterectomy Trial (NASCET). Stroke. 1999;30(9):1759–63.PubMedCrossRef
16.
go back to reference Lal BK, Dux MC, Sikdar S, Goldstein C, Khan AA, Yokemick J, et al. Asymptomatic carotid stenosis is associated with cognitive impairment. J Vasc Surg. 2017;66(4):1083–92.PubMedCrossRef Lal BK, Dux MC, Sikdar S, Goldstein C, Khan AA, Yokemick J, et al. Asymptomatic carotid stenosis is associated with cognitive impairment. J Vasc Surg. 2017;66(4):1083–92.PubMedCrossRef
17.
go back to reference Valaikiene J, Schuierer G, Ziemus B, Dietrich J, Bogdahn U, Schlachetzki F. Transcranial color-coded duplex sonography for detection of distal internal carotid artery stenosis. AJNR Am J Neuroradiol. 2008;29(2):347–53.PubMedCrossRef Valaikiene J, Schuierer G, Ziemus B, Dietrich J, Bogdahn U, Schlachetzki F. Transcranial color-coded duplex sonography for detection of distal internal carotid artery stenosis. AJNR Am J Neuroradiol. 2008;29(2):347–53.PubMedCrossRef
18.
go back to reference Lip SV, Boekschoten MV, Hooiveld GJ, Pampus MGV, Scherjon SA, Plosch T, et al. Early-onset preeclampsia, plasma microRNAs and endothelial cell function. Am J Obstet Gynecol. 2020;222(5):497.e1-497.e12. Lip SV, Boekschoten MV, Hooiveld GJ, Pampus MGV, Scherjon SA, Plosch T, et al. Early-onset preeclampsia, plasma microRNAs and endothelial cell function. Am J Obstet Gynecol. 2020;222(5):497.e1-497.e12.
19.
go back to reference Monfared YK, Honardoost M, Sarookhani MR, Farzam SA. Circulating miR-135 may serve as a novel co-biomarker of HbA1c in type 2 diabetes. Appl Biochem Biotechnol. 2020;191(2):623-30. Monfared YK, Honardoost M, Sarookhani MR, Farzam SA. Circulating miR-135 may serve as a novel co-biomarker of HbA1c in type 2 diabetes. Appl Biochem Biotechnol. 2020;191(2):623-30.
20.
go back to reference Badacz R, Przewlocki T, Gacon J, Stepien E, Enguita FJ, Karch I, et al. Circulating miRNA levels differ with respect to carotid plaque characteristics and symptom occurrence in patients with carotid artery stenosis and provide information on future cardiovascular events. Postepy Kardiol Interwencyjnej. 2018;14(1):75–84.PubMedPubMedCentral Badacz R, Przewlocki T, Gacon J, Stepien E, Enguita FJ, Karch I, et al. Circulating miRNA levels differ with respect to carotid plaque characteristics and symptom occurrence in patients with carotid artery stenosis and provide information on future cardiovascular events. Postepy Kardiol Interwencyjnej. 2018;14(1):75–84.PubMedPubMedCentral
21.
go back to reference Wu J, Song J, Wang C, Niu D, Li H, Liu Y, et al. Identification of serum microRNAs for cardiovascular risk stratification in dyslipidemia subjects. Int J Cardiol. 2014;172(1):232–4.PubMedCrossRef Wu J, Song J, Wang C, Niu D, Li H, Liu Y, et al. Identification of serum microRNAs for cardiovascular risk stratification in dyslipidemia subjects. Int J Cardiol. 2014;172(1):232–4.PubMedCrossRef
22.
go back to reference Jiang J, Mo H, Liu C, Wu B, Wu Z, Li X, et al. Inhibition of miR-186-5p contributes to high glucose-induced injury in AC16 cardiomyocytes. Exp Ther Med. 2018;15(1):627–32.PubMed Jiang J, Mo H, Liu C, Wu B, Wu Z, Li X, et al. Inhibition of miR-186-5p contributes to high glucose-induced injury in AC16 cardiomyocytes. Exp Ther Med. 2018;15(1):627–32.PubMed
23.
go back to reference Balci S, Ayaz L, Gorur A, Yildirim Yaroglu H, Akbayir S, Dogruer Unal N, et al. microRNA profiling for early detection of nonmelanoma skin cancer. Clin Exp Dermatol. 2016;41(4):346–51.PubMedCrossRef Balci S, Ayaz L, Gorur A, Yildirim Yaroglu H, Akbayir S, Dogruer Unal N, et al. microRNA profiling for early detection of nonmelanoma skin cancer. Clin Exp Dermatol. 2016;41(4):346–51.PubMedCrossRef
24.
go back to reference Summerer I, Unger K, Braselmann H, Schuettrumpf L, Maihoefer C, Baumeister P, et al. Circulating microRNAs as prognostic therapy biomarkers in head and neck cancer patients. Br J Cancer. 2015;113(1):76–82.PubMedPubMedCentralCrossRef Summerer I, Unger K, Braselmann H, Schuettrumpf L, Maihoefer C, Baumeister P, et al. Circulating microRNAs as prognostic therapy biomarkers in head and neck cancer patients. Br J Cancer. 2015;113(1):76–82.PubMedPubMedCentralCrossRef
25.
go back to reference Paraskevas KI, Mikhailidis DP, Veith FJ, Spence JD. Definition of best medical treatment in asymptomatic and symptomatic carotid artery stenosis. Angiology. 2016;67(5):411–9.PubMedCrossRef Paraskevas KI, Mikhailidis DP, Veith FJ, Spence JD. Definition of best medical treatment in asymptomatic and symptomatic carotid artery stenosis. Angiology. 2016;67(5):411–9.PubMedCrossRef
26.
go back to reference Zhang L, Liu J, Cheng P, Lv F. Correlation between miRNA target site polymorphisms in the 3′ UTR of AVPR1A and the risk of hypertension in the Chinese Han population. Biosci Rep. 2019;39(5):BSR20182232.PubMedPubMedCentralCrossRef Zhang L, Liu J, Cheng P, Lv F. Correlation between miRNA target site polymorphisms in the 3′ UTR of AVPR1A and the risk of hypertension in the Chinese Han population. Biosci Rep. 2019;39(5):BSR20182232.PubMedPubMedCentralCrossRef
27.
go back to reference Chiquete E, Torres-Octavo B, Cano-Nigenda V, Valle-Rojas D, Dominguez-Moreno R, Tolosa-Tort P, et al. Characterisation of factors associated with carotid stenosis in a population at high risk [Caracterizacion de factores asociados con estenosis carotidea en una poblacion de alto riesgo]. Rev Neurol. 2014;58(12):541–7.PubMed Chiquete E, Torres-Octavo B, Cano-Nigenda V, Valle-Rojas D, Dominguez-Moreno R, Tolosa-Tort P, et al. Characterisation of factors associated with carotid stenosis in a population at high risk [Caracterizacion de factores asociados con estenosis carotidea en una poblacion de alto riesgo]. Rev Neurol. 2014;58(12):541–7.PubMed
Metadata
Title
Diagnostic value of miR-186-5p for carotid artery stenosis and its predictive significance for future cerebral ischemic event
Authors
Weibo Lv
Tao Zhang
Hongwei Zhao
Shuang He
Bingwei Li
Yang Gao
Wenying Pan
Publication date
01-12-2020
Publisher
BioMed Central
Published in
Diagnostic Pathology / Issue 1/2020
Electronic ISSN: 1746-1596
DOI
https://doi.org/10.1186/s13000-020-01007-w

Other articles of this Issue 1/2020

Diagnostic Pathology 1/2020 Go to the issue